522
Views
3
CrossRef citations to date
0
Altmetric
Clinical Study

Dramatic Decrease of Carnitine Esters after Interruption of Exogenous Carnitine Supply in Hemodialysis Patients

, , , &
Pages 555-558 | Received 17 Oct 2011, Accepted 01 Feb 2010, Published online: 15 Mar 2012

REFERENCES

  • Bremer J. Carnitine – metabolism and functions. Physiol Rev. 1983;63:1420–1480.
  • Bieber LL. Carnitine. Annu Rev Biochem. 1988;57:261–283.
  • Melegh B, Sumegi B, Sherry AD. Preferential elimination of pivalate with supplemental carnitine via formation of pivaloylcarnitine in man. Xenobiotica. 1993;23:1255–1261.
  • Melegh B, Pap M, Morava E, Molnar D, Dani M, Kurucz J. Carnitine-dependent changes of metabolic fuel consumption during long-term treatment with valproic acid. J Pediatr. 1994; 125:317–321.
  • Vaz FM, Melegh B, Bene J, . Analysis of carnitine biosynthesis metabolites in urine by HPLC-electrospray tandem mass spectrometry. Clin Chem. 2002;48:826–834.
  • Melegh B, Kerner J, Sandor A, Vinceller M, Kispal G. Effects of oral L-carnitine supplementation in low-birth-weight premature infants maintained on human milk. Biol Neonate. 1987; 51:185–193.
  • Melegh B, Kerner J, Acsadi G, Lakatos J, Sandor A. L-carnitine replacement therapy in chronic valproate treatment. Neuropediatrics. 1990;21:40–43.
  • Kispal G, Melegh B, Alkonyi I, Sandor A. Enhanced uptake of carnitine by perfused rat liver following starvation. Biochim Biophys Acta. 1987;896:96–102.
  • Pace S, Longo A, Toon S, Rolan P, Evans AM. Pharmacokinetics of propionyl-L-carnitine in humans: Evidence for saturable tubular reabsorption. Br J Clin Pharmacol. 2000;50:441–448.
  • Rumpf KW, Leschke M, Eisenhauer T, Becker K, Köthe U, Scheler F. Quantitative assessment of carnitine loss during hemodialysis and hemofiltration. Proc Eur Dial Transplant Assoc. 1983;19:298–301.
  • Reuter SE, Evans AM, Faull RJ, Chace DH, Fornasini G. Impact of hemodialysis on individual endogenous plasma acylcarnitine concentrations in end-stage renal disease. Ann Clin Biochem. 2005;42:387–393.
  • Bene J, Csiky B, Komlosi K, Sulyok E, Melegh B. Dynamic adaptive changes of the serum carnitine esters during and after L-carnitine supplementation in patients with maintenance hemodialysis. Scand J Clin Lab Invest. 2011;71:280–286.
  • Bene J, Komlosi K, Magyari L, . Plasma carnitine ester profiles in Crohn’s disease patients characterized for SLC22A4 C1672T and SLC22A5 G-207C genotypes. Br J Nutr. 2007;98:345–350.
  • Brass EP, Adler S, Sietsema KE, . Intravenous L-carnitine increases plasma carnitine, reduces fatigue, and may preserve exercise capacity in hemodialysis patients. Am J Kidney Dis. 2001;37:1018–1028.
  • Calvani M, Benatti P, Mancinelli A, . Carnitine replacement in end-stage renal disease and hemodialysis. Ann N Y Acad Sci. 2004;1033:52–66.
  • Reuter SE, Faull RJ, Evans AM. L-carnitine supplementation in the dialysis population: Are Australian patients missing out? Nephrology (Carlton). 2008;13:3–16.
  • Bellinghieri G, Santoro D, Calvani M, Mallamace A, Savica V. Carnitine and hemodialysis. Am J Kidney Dis. 2003;41:S116–122.
  • Evans AM, Faull R, Fornasini G, . Pharmacokinetics of L-carnitine in patients with end-stage renal disease undergoing long-term hemodialysis. Clin Pharmacol Ther. 2000; 68:238–249.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.